Search results (269)
« Back to PublicationsCE2 inhibition ELISA is an effective surrogate for SARS-CoV-2 live virus neutralisation
Journal article
Tipton T. et al, (2026), Vaccine, 72, 128123 - 128123
Screening of FDA-approved drugs using a recombinant Cedar virus to improve treatment options for Nipah virus infection.
Journal article
Clayton E. et al, (2026), The Journal of general virology, 107
Current knowledge on the host-pathogen interactions of henipaviruses and novel platforms to enable further characterisation.
Journal article
Hantabal J. et al, (2026), EBioMedicine, 123
Discontinuous EBOV RNA synthesis events in patients with Ebola virus disease and their relationship to viral load and outcome of infection.
Journal article
Dong X. et al, (2025), Journal of virology, 99
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunity
Journal article
Kronsteiner B. et al, (2025), Scientific Reports, 15
Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine.
Journal article
Pfranger M. et al, (2025), The Journal of general virology, 106
Efficacy of inhaled nebulised unfractionated heparin to prevent intubation or death in hospitalised patients with COVID-19: an investigator-initiated international meta-trial of randomised clinical studies.
Journal article
van Haren FMP. et al, (2025), EClinicalMedicine, 88
Drivers of Crimean-Congo Hemorrhagic Fever in Natural Host and Effects of Control Measures, Bulgaria.
Journal article
Limon G. et al, (2025), Emerging infectious diseases, 31, 1738 - 1746
Hamsters immunized with formalin-inactivated SARS-CoV-2 develop accelerated lung histopathological lesions and Th2-biased response following infection.
Journal article
de Jong R. et al, (2025), NPJ vaccines, 10
Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies.
Journal article
Laczi D. et al, (2025), European journal of medicinal chemistry, 291
SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management.
Journal article
Nguyen D. et al, (2025), Journal of virology, 99
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials
Journal article
Chan XHS. et al, (2025), The Lancet Microbe, 6, 101002 - 101002
Longitudinal Immunoprofiling of the CD8+ T-Cell Response in SARS-CoV-2 mRNA Vaccinees and COVID-19 Patients.
Journal article
Brunetti JE. et al, (2025), Vaccines, 13
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal immunity– an observational cohort study
Preprint
Dunachie S. et al, (2025)
Detection of mpox and other orthopoxviruses using a lateral flow device as a point-of-care diagnostic
Journal article
Laidlaw SM. et al, (2025), Microbiology Spectrum, 13